Journals / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 5

Assessment of Ankaferd Blood Stopper in experimental liver ischemia reperfusion injury

Pages
1421–1427
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Bölümü, Cerrahi Onkoloji Anabilim Dalı, Ankara, Türkiye 2Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Bölümü, Gastrointestinal Cerrahi Anabilim Dalı, Ankara, Türkiye Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Anabilim Dalı, Ankara, Türkiye

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: To investigate possible protective effects of Ankaferd Blood Stopper® (ABS) in an experimental liver ischemia reperfusion injury (IRI) model.
📊
Key Findings & Data:Materials and methods: The study was carried out on 30 female rats separated into 3 groups as sham, control (IRI), and treatment (IRI + ABS) groups.
💡
Conclusion & Impact:Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Bölümü, Cerrahi Onkoloji Anabilim Dalı, Ankara, Türkiye 2Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Bölümü, Gastrointestinal Cerrahi Anabilim Dalı, Ankara, Türkiye Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Anabilim Dalı, Ankara, Türkiye
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: To investigate possible protective effects of Ankaferd Blood Stopper® (ABS) in an experimental liver ischemia reperfusion injury (IRI) model. Materials and methods: The study was carried out on 30 female rats separated into 3 groups as sham, control (IRI), and treatment (IRI + ABS) groups. In the IRI + ABS group, 0.5 mL/day ABS was given for 7 days before surgery. In the IRI and IRI + ABS groups, the hepatic pedicle was clamped for 30 min to apply ischemia. Then, after opening the clamp, 90-min reperfusion of the liver was provided. Blood and liver tissue samples were taken for biochemical and histopathological analyses. Results: Compared to the sham group, the IRI group had significantly higher levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total oxidant status (TOS), malondialdehyde (MDA), fluorescent oxidant products (FOP) and lower expression of albumin and total antioxidant status (TAS) (P < 0.05). Compared to the IRI group, the IRI+ABS group showed lower expression of AST, ALT, TOS, MDA and FOP and higher expression of albumin and TAS (P < 0.05). In the histopathological analysis, congestion scores were statistically significantly lower in the IRI + ABS group than in the IRI group. Conclusions: ABS has a strong hepatoprotective effect due to its antioxidant and antiinflammatory effects and could therefore be used as a potential therapeutic agent for IRI. Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Bölümü, Cerrahi Onkoloji Anabilim Dalı, Ankara, Türkiye 2Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Bölümü, Gastrointestinal Cerrahi Anabilim Dalı, Ankara, Türkiye Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Anabilim Dalı, Ankara, Türkiye

🔖

Cite This Article

SÜLEYMAN, M., ERSAK, C., KARAAHMET, F., DURHAN, A., KUŞABBİ, İ. A., ŞENES, M., TEZ, M., ESER, E. P., HÜCÜMENOĞLU, S., KOŞMAZ, K., ŞENLİKCİ, A., PEKÇİCİ, R., ÜNAL, Y. (2022). Assessment of Ankaferd Blood Stopper in experimental liver ischemia reperfusion injury. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 5, 1421–1427. https://ajindex.com/articles/610056

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng YL et al. Current mechanistic concepts in ischemia and reperfusion injury. Cellular Physiology and Biochemistry 2018
  2. 46 (4): 1650-1667. doi: 10.1159/000489241 2. Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH. Molecular biology of apoptosis in ischemia and reperfusion. Journal of Investigative Surgery 2005
  3. 18 (6): 335-350. doi: 10.1080/08941930500328862 3. Ornellas FM, Ornellas DS, Martini SV, Castiglione RC, Ventura GM et al. Bone marrow-derived mononuclear cell therapy accelerates renal ischemia-reperfusion injury recovery by modulating inflammatory, antioxidant and apoptotic related molecules. Cellular Physiology and Biochemistry 2017
  4. 41 (5): 1736-1752. doi: 10.1159/000471866 4. Ling Q, Yu X, Wang T, Wang SG, Ye ZQ et al. Roles of the exogenous H2S-mediated SR-A signaling pathway in renal ischemia/ reperfusion injury in regulating endoplasmic reticulum stress-induced autophagy in a rat model. Cellular Physiology and Biochemistry 2017
  5. 41 (6): 2461-2474. doi: 10.1159/000475915 5. Guan LY, Fu PY, Li PD, Li ZN, Liu HY et al. Mechanisms of hepatic ischemia-reperfusion injury and protective effects of nitric oxide. World Journal of Gastrointestinal Surgery 2014
  6. 6 (7): 122-128. doi: 10.4240/wjgs.v6.i7.122 6. Cannistra M, Ruggiero M, Zullo A, Gallelli G, Serafini S et al. Hepatic ischemia reperfusion injury: a systematic review of literature and the role of current drugs and biomarkers. International Journal of Surgery 2016
  7. 33 (Suppl 1): S57-70. doi: 10.1016/j.ijsu 7. Huguet C, Addario-Chieco P, Gavelli A, Arrigo E, Harb J et al. Technique of hepatic vascular exclusion for extensive liver resection. American Journal of Surgery 1992
  8. 163 (6): 602-605. doi: 10.1016/0002-9610(92)90567-b 8. Jiang X, Kuang G, Gong X, Jiang R, Xie T et al. Glycyrrhetinic acid pretreatment attenuates liver ischemia/reperfusion injury via inhibiting TLR4 signaling cascade in mice. International Immunopharmacology 2019
  9. 105870. doi: 10.1016/j. intimp.2019.105870 9. Ünal Y, Küçük B, Tuncal S, Koşmaz K, Çavuşoğlu NT et al. Assessment of the effect of calcium dobesilate in experimental liver ischemia-reperfusion injury. Ulus Travma Acil Cerrahi Dergisi 2018
  10. 24 (5): 391-397. doi: 10.5505/tjtes.2018.33238 10. Park HK, Kang SW, Park MS. Hesperidin ameliorates hepatic ischemia-reperfusion injury in Sprague-Dawley rats. Transplantation Proceedings 2019
  11. 51 (8): 2828‐2832. doi: 10.1016/j.transproceed.2019.02.059 11. Goker H, Haznedaroglu IC,